| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 15 | 208 | 45 | - | - | 268 |
| - | - | - | - | - | - | 7 | 1 | - | - | 8 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| 5 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 118 |
| 308 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 95 | 24.5% | 1.16 | 213 | 65.7% |
| ME(L) | 268 | 69.1% | -5.07 | 8 | 2.5% |
| SCL(L) | 16 | 4.1% | 1.36 | 41 | 12.7% |
| ICL(L) | 5 | 1.3% | 2.81 | 35 | 10.8% |
| CentralBrain-unspecified | 2 | 0.5% | 3.25 | 19 | 5.9% |
| AME(L) | 0 | 0.0% | inf | 5 | 1.5% |
| Optic-unspecified(L) | 2 | 0.5% | 0.58 | 3 | 0.9% |
| upstream partner | # | NT | conns MeVP20 | % In | CV |
|---|---|---|---|---|---|
| Mi17 (L) | 31 | GABA | 109 | 30.4% | 0.6 |
| MeLo5 (L) | 15 | ACh | 62 | 17.3% | 0.6 |
| Cm34 (L) | 1 | Glu | 18 | 5.0% | 0.0 |
| Cm7 (L) | 3 | Glu | 16 | 4.5% | 0.3 |
| Cm8 (L) | 9 | GABA | 15 | 4.2% | 0.6 |
| CL340 (L) | 2 | ACh | 14 | 3.9% | 0.1 |
| SLP003 (L) | 1 | GABA | 11 | 3.1% | 0.0 |
| SLP004 (L) | 1 | GABA | 10 | 2.8% | 0.0 |
| aMe22 (L) | 1 | Glu | 8 | 2.2% | 0.0 |
| PLP145 (L) | 1 | ACh | 8 | 2.2% | 0.0 |
| SLP360_d (L) | 2 | ACh | 7 | 2.0% | 0.1 |
| MeVC2 (R) | 1 | ACh | 6 | 1.7% | 0.0 |
| SLP360_c (L) | 1 | ACh | 5 | 1.4% | 0.0 |
| PLP120 (L) | 1 | ACh | 5 | 1.4% | 0.0 |
| DNpe035 (L) | 1 | ACh | 4 | 1.1% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 3 | 0.8% | 0.0 |
| MeVP46 (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| LoVP8 (L) | 3 | ACh | 3 | 0.8% | 0.0 |
| MeLo6 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| Tm20 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CL134 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| PLP095 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 2 | 0.6% | 0.0 |
| MeVC27 (R) | 1 | unc | 2 | 0.6% | 0.0 |
| MeVC4b (R) | 1 | ACh | 2 | 0.6% | 0.0 |
| Cm4 (L) | 2 | Glu | 2 | 0.6% | 0.0 |
| Cm16 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LoVP28 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| DNp27 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL086_a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP131 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVP58 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVP16 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| SLP438 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| SMP328_a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Tm34 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AOTU058 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| Tm5c (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LoVP4 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Cm6 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| AOTU056 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| Tm37 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| TmY3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL102 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP340 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP045 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CL125 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| MeVP21 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LoVP74 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVP62 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP069 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVP43 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVP96 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| Pm13 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LoVC18 (L) | 1 | DA | 1 | 0.3% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.3% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns MeVP20 | % Out | CV |
|---|---|---|---|---|---|
| PLP145 (L) | 1 | ACh | 80 | 12.0% | 0.0 |
| PLP120 (L) | 1 | ACh | 71 | 10.6% | 0.0 |
| CL134 (L) | 2 | Glu | 45 | 6.7% | 1.0 |
| PLP129 (L) | 1 | GABA | 42 | 6.3% | 0.0 |
| SLP360_d (L) | 2 | ACh | 36 | 5.4% | 0.3 |
| SMP201 (L) | 1 | Glu | 33 | 4.9% | 0.0 |
| SLP360_c (L) | 1 | ACh | 28 | 4.2% | 0.0 |
| KCg-d (L) | 14 | DA | 22 | 3.3% | 0.5 |
| CL327 (L) | 1 | ACh | 21 | 3.1% | 0.0 |
| CL352 (L) | 1 | Glu | 20 | 3.0% | 0.0 |
| aMe26 (L) | 3 | ACh | 17 | 2.5% | 0.1 |
| SLP358 (L) | 1 | Glu | 16 | 2.4% | 0.0 |
| CL356 (L) | 2 | ACh | 15 | 2.2% | 0.9 |
| SMP340 (L) | 1 | ACh | 12 | 1.8% | 0.0 |
| LoVP60 (L) | 1 | ACh | 11 | 1.6% | 0.0 |
| LoVP58 (L) | 1 | ACh | 10 | 1.5% | 0.0 |
| CL014 (L) | 3 | Glu | 9 | 1.3% | 0.7 |
| MeTu4e (L) | 6 | ACh | 9 | 1.3% | 0.3 |
| SMP022 (L) | 1 | Glu | 7 | 1.0% | 0.0 |
| SMP459 (L) | 1 | ACh | 6 | 0.9% | 0.0 |
| SLP360_a (L) | 1 | ACh | 5 | 0.7% | 0.0 |
| aMe26 (R) | 1 | ACh | 5 | 0.7% | 0.0 |
| PLP149 (L) | 2 | GABA | 5 | 0.7% | 0.6 |
| aMe4 (L) | 2 | ACh | 5 | 0.7% | 0.6 |
| SLP295 (L) | 2 | Glu | 5 | 0.7% | 0.2 |
| CL269 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CB0943 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CL244 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| PLP094 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| MeVP12 (L) | 2 | ACh | 4 | 0.6% | 0.5 |
| Mi17 (L) | 4 | GABA | 4 | 0.6% | 0.0 |
| CL070_b (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| LC33 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| MeVP38 (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| CB1876 (L) | 2 | ACh | 3 | 0.4% | 0.3 |
| aMe17b (L) | 2 | GABA | 3 | 0.4% | 0.3 |
| Cm8 (L) | 3 | GABA | 3 | 0.4% | 0.0 |
| CB0656 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP424 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL357 (L) | 1 | unc | 2 | 0.3% | 0.0 |
| KCg-m (L) | 1 | DA | 2 | 0.3% | 0.0 |
| LoVP56 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL086_c (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| AVLP522 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PLP119 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| KCg-s1 (L) | 1 | DA | 2 | 0.3% | 0.0 |
| MeVP61 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL086_a (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| DNpe035 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL357 (R) | 1 | unc | 2 | 0.3% | 0.0 |
| SLP170 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| Tm34 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| MeVP16 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| SMP331 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| PLP069 (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| SMP327 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3676 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP180 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT68 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP51 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL254 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe8 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CB3001 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP8 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP069 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL070_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL031 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP332 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0937 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3360 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP398 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu4c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu4a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1733 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1551 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP077 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP174 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm27 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Pm4 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| AOTU047 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LC34 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP375 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL152 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm25 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo3b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP38 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP39 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL125 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP121 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP79 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP42 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP207 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP250 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP30 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP43 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DNp101 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP004 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVC20 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC27 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| CL063 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| mALD1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |